// App-Quantinova.ai

: The VTE PRO: A Double Blind, Randomized Control Trial Comparing Extended, Post-Discharge Venous Thromboembolic Events Prophylaxis with Placebo in Patients Undergoing Major Oncological Lung Resections

Researchers

Presenter

  • Yaron Shargall

Principal Investigators

  • Yessica Lopez-Hernandez

  • Terri Schnurr

  • Laura Schneider

  • Lori-Ann Linkins

  • Mark Crowther

  • John Agzarian

  • Waal C. Hanna

  • Christian J. Finley

  • Thomas K. Waddell

  • Marc De Perrot

  • James Douketis

Medical Centers

  • McMaster University, Hamilton, ON, Canada

  • University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Anti-Müllerian hormone

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved